flindersine has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandramohan, G; Duraipandiyan, V; Ignacimuthu, S; Irudayaraj, SS; Jincy, J; Packiam, SM; Sunil, C | 1 |
1 other study(ies) available for flindersine and Alloxan Diabetes
| Article | Year |
|---|---|
Antidiabetic with antilipidemic and antioxidant effects of flindersine by enhanced glucose uptake through GLUT4 translocation and PPARĪ³ agonism in type 2 diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Glutathione Peroxidase; Heterocyclic Compounds, 3-Ring; Hypoglycemic Agents; Hypolipidemic Agents; Male; Molecular Structure; Phytotherapy; Plant Extracts; PPAR gamma; Rats; Rats, Wistar; Rutaceae; Superoxide Dismutase | 2022 |